MediciNova, Inc. (4875.T)
JPY 206.0
(-0.96%)
JPY 206.0
(-0.96%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | -7.43 Million | -12.91 Million | -9.38 Million | -10.82 Million | - |
| Net Income | -8.57 Million | -14.06 Million | -10.13 Million | -13.85 Million | - |
| Depreciation & Amortization | 20.29 Thousand | 17.7 Thousand | 26.14 Thousand | 21.34 Thousand | - |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | 710.71 Thousand | 642.52 Thousand | 1.71 Million | 3.17 Million | - |
| Change in working capital | 111.98 Thousand | 334.1 Thousand | -1.2 Million | -379.57 Thousand | - |
| Other non-cash items | -151.88 Thousand | 40.71 Thousand | 216.64 Thousand | 210.21 Thousand | - |
| Investing Cash Flow | 39.9 Million | -40 Million | -28.73 Thousand | -36.49 Thousand | - |
| Investments in PPE | -21.29 Thousand | -5010.00 | -28.73 Thousand | -36.49 Thousand | - |
| Acquisitions | - | - | - | - | - |
| Investment purchases | - | -59.87 Million | - | - | - |
| Sales/Maturities of investments | 39.92 Million | 19.87 Million | - | - | - |
| Other Investing Activities | 39.92 Million | - | - | - | - |
| Financing Cash Flow | - | 7920.00 | 20.77 Million | 7.1 Million | - |
| Debt repayment | - | - | - | - | - |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | - | 7920.00 | 20.89 Million | 7.29 Million | - |
| Other Financing Activities | - | - | -118.36 Thousand | -203.84 Thousand | -288.36 Thousand |
| Accounts receivables | - | - | - | - | - |
| Accounts payables | 19.23 Thousand | 329.01 Thousand | -1.02 Million | -4772.00 | - |
| Inventory | - | - | - | - | - |
| Other working capital | 92.74 Thousand | - | - | - | - |
| Cash at beginning of period | 18.5 Million | 71.43 Million | 60.03 Million | 63.79 Million | - |
| Cash at end of period | 50.99 Million | 18.5 Million | 71.43 Million | 60.03 Million | - |
| Capital Expenditure | -21.29 Thousand | -5010.00 | -28.73 Thousand | -36.49 Thousand | - |
| Effect of forex changes on cash | 17.27 Thousand | -16.8 Thousand | 26.54 Thousand | 1201.00 | - |
| Net cash flow / Change in cash | 32.49 Million | -52.92 Million | 11.39 Million | -3.75 Million | - |
| Free Cash Flow | -7.45 Million | -12.91 Million | -9.41 Million | -10.86 Million | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -2.62 Million | -2.75 Million | -2.05 Million | -8.57 Million | -723.1 Thousand | -2.87 Million |
| Depreciation & Amortization | 5370.00 | 5350.00 | 5492.00 | 20.29 Thousand | 5703.00 | 4995.00 |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 207.45 Thousand | 215.43 Thousand | -237.4 Thousand | 710.71 Thousand | 219.14 Thousand | 325.71 Thousand |
| Change in working capital | -431.75 Thousand | -1.38 Million | 1.74 Million | 111.98 Thousand | -921.22 Thousand | 108.97 Thousand |
| Other non-cash items | 36.2 Thousand | 49.39 Thousand | -298.09 Thousand | -151.88 Thousand | 47.56 Thousand | 49.12 Thousand |
| Investing Cash Flow | -891.00 | - | 22.00 | 39.9 Million | -2744.00 | -18.57 Thousand |
| Investments in PPE | -891.00 | - | 22.00 | -21.29 Thousand | -2744.00 | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | 39.92 Million | - | - |
| Other Investing Activities | -891.00 | - | - | - | - | - |
| Financing Cash Flow | - | - | - | - | - | - |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | - | - | - | - |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 507.00 | -781.34 Thousand | 476.91 Thousand | 19.23 Thousand | -28.79 Thousand | 30.37 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | -432.26 Thousand | - | - | - | - | - |
| Cash at beginning of period | 47.13 Million | 50.99 Million | 51.5 Million | 18.5 Million | 52.87 Million | 55.25 Million |
| Cash at end of period | 44.33 Million | 47.13 Million | 50.99 Million | 50.99 Million | 51.5 Million | 52.87 Million |
| Capital Expenditure | -891.00 | - | 22.00 | -21.29 Thousand | -2744.00 | - |
| Effect of forex changes on cash | 10.84 Thousand | 7605.00 | -8881.00 | 17.27 Thousand | 5383.00 | 18.49 Thousand |
| Net cash flow / Change in cash | -2.8 Million | -3.86 Million | -507.91 Thousand | 32.49 Million | -1.36 Million | -2.38 Million |
| Free Cash Flow | -2.81 Million | -3.86 Million | -499.03 Thousand | -7.45 Million | -1.37 Million | -2.38 Million |
6485
FROG
4004
4577
9790
0K9J